We believe that once more cardiologists become aware of the test, it will become the new standard of care in CAD risk assessment and CAD treatment follow-up.
New York, NY (PRWEB) November 08, 2011
The superior diagnostic accuracy of the Oxidized LDL Triple Marker Test in identifying patients with coronary artery disease will be presented at the American Heart Association’s Scientific Sessions 2011, November 12-16, 2011 at the Orange County Convention Center in Orlando Florida.
Shiel Medical Laboratory will present its exclusive Oxidized LDL Triple Marker Test for cardiologists and cardiology researchers at booth 1559. As part of the demonstration, the Oxidized LDL Triple Marker Test and the traditional lipid panel containing total cholesterol, triglycerides, LDL-cholesterol and HDL will be drawn and performed on conference attendees' blood samples. The demonstration will enable cardiologists and researchers to compare their traditional coronary artery disease risk assessment results with the Oxidized LDL Triple Marker test.
First introduced to the market in 2007 by Shiel Medical Laboratory, the Oxidized LDL Triple Marker test has been used by more than 150,000 patients to assess their risk of Coronary Artery Disease (CAD). With a simple blood draw, the Oxidized LDL Triple Marker test provides actionable information that helps clinicians make better decisions on how aggressively or non-aggressively to treat a patient with borderline results. It also helps identify patients at risk who may not be clearly indicated by the traditional lipid panel.
"The Oxidized LDL Triple Marker test is a major advance in cardiac health evaluation," said Harold M. Bates, Ph.D. of Shiel Medical Laboratory. "Numerous studies have shown that the Oxidized LDL test identifies 52 percent more patients with documented coronary artery disease than the conventional, time-honored LDL-cholesterol test. We believe that once more cardiologists become aware of the test, it will become the new standard of care in CAD risk assessment and CAD treatment follow-up.”
Oxidized LDL is a plaque-specific protein involved in all stages of coronary artery disease. Oxidized LDL is found only in atherosclerotic plaques and not in normal artery walls. The CAD process cannot initiate or progress until the oxidation of LDL occurs. Oxidized LDL is the atherogenic form of LDL and is responsible for the initiation and progression of plaque in the arteries. HDL is anti-atherogenic and prevents plaque formation. The Oxidized LDL Triple Marker test is the only blood test that reflects atherosclerotic disease activity in the artery wall.
More information regarding Shiel Medical Laboratory and its Oxidized LDL Triple Marker test is available at http://www.shiel.com. or contact us at 1 800-553-0873, Ext 1900.
About Shiel Medical Laboratory
In business since 1919, Shiel Medical Laboratory's main lab facility is located in the historic Brooklyn Navy Yard. Its 35,000 square foot laboratory allows Shiel to service clientele with the highest level of efficiency and accuracy while maintaining their position as the fastest growing regional laboratory in the New York Metropolitan area. Shiel's state-of-the-art facility provides physicians and patients with an expansive range of clinical laboratory testing services. Shiel's commitment to accuracy, reliability and efficiency makes it a respected choice for quality clinical diagnostics.
About American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – America’s No. 1 and No. 3 killers. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country.